Filing Details

Accession Number:
0001209191-20-040351
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-02 16:36:43
Reporting Period:
2020-07-01
Accepted Time:
2020-07-02 16:36:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1426332 Ngm Biopharmaceuticals Inc NGM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1642996 Jin-Long Chen 333 Oyster Point Boulevard
South San Francisco CA 94080
Chief Scientific Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-07-01 17,737 $18.79 1,027,268 No 4 S Direct
Common Stock Disposition 2020-07-01 7,263 $19.20 1,020,005 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020.
  2. Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $18.105 to $19.095. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $19.10 to $19.315. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.